A. Rachel Leheny - Net Worth and Insider Trading

A. Rachel Leheny Net Worth

The estimated net worth of A. Rachel Leheny is at least $4 Million dollars as of 2024-06-03. A. Rachel Leheny is the CEO, 10% Owner of CalciMedica Inc and owns about 759,166 shares of CalciMedica Inc (CALC) stock worth over $4 Million. Details can be seen in A. Rachel Leheny's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that A. Rachel Leheny has not made any transactions after 2023-11-07 and currently still holds the listed stock(s).

Transaction Summary of A. Rachel Leheny

To

A. Rachel Leheny Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, A. Rachel Leheny owns 1 companies in total, including CalciMedica Inc (CALC) .

Click here to see the complete history of A. Rachel Leheny’s form 4 insider trades.

Insider Ownership Summary of A. Rachel Leheny

Ticker Comapny Transaction Date Type of Owner
CALC CalciMedica Inc 2023-11-07 director & 10 percent owner & Chief Executive Officer

A. Rachel Leheny Latest Holdings Summary

A. Rachel Leheny currently owns a total of 1 stock. A. Rachel Leheny owns 759,166 shares of CalciMedica Inc (CALC) as of November 7, 2023, with a value of $4 Million.

Latest Holdings of A. Rachel Leheny

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CALC CalciMedica Inc 2023-11-07 759,166 5.69 4,319,655

Holding Weightings of A. Rachel Leheny


A. Rachel Leheny Form 4 Trading Tracker

According to the SEC Form 4 filings, A. Rachel Leheny has made a total of 11 transactions in CalciMedica Inc (CALC) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in CalciMedica Inc is the acquisition of 2,000 shares on November 7, 2023, which cost A. Rachel Leheny around $6,680.

Insider Trading History of A. Rachel Leheny

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

A. Rachel Leheny Trading Performance

GuruFocus tracks the stock performance after each of A. Rachel Leheny's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by A. Rachel Leheny is 8.86%. GuruFocus also compares A. Rachel Leheny's trading performance to market benchmark return within the same time period. The performance of stocks bought by A. Rachel Leheny within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how A. Rachel Leheny's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of A. Rachel Leheny

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.14 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.41 LIMIT LIMIT LIMIT LIMIT LIMIT

A. Rachel Leheny Ownership Network

Ownership Network List of A. Rachel Leheny

No Data

Ownership Network Relation of A. Rachel Leheny

Insider Network Chart

A. Rachel Leheny Owned Company Details

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

A. Rachel Leheny is the director & 10 percent owner & Chief Executive Officer of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, A. Rachel Leheny made 11 insider transaction in CalciMedica Inc (CALC) with a net purchase of 20,768. Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 691,098 shares made by Fred A Middleton , and a net purchase of 2,255 shares made by Eric Bjerkholt .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CalciMedica Inc Insider Transactions

No Available Data

A. Rachel Leheny Mailing Address

Above is the net worth, insider trading, and ownership report for A. Rachel Leheny. You might contact A. Rachel Leheny via mailing address: C/o Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B, Hayward Ca 94545.

Discussions on A. Rachel Leheny

No discussions yet.